Log in to save to my catalogue

Efficacy and metabolomic analysis of the pneumonia compound formulation against community-acquired p...

Efficacy and metabolomic analysis of the pneumonia compound formulation against community-acquired p...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8f58dd06bb8c4508a8d6feb357df91a1

Efficacy and metabolomic analysis of the pneumonia compound formulation against community-acquired pneumonia: an observational controlled before-after clinical trial

About this item

Full title

Efficacy and metabolomic analysis of the pneumonia compound formulation against community-acquired pneumonia: an observational controlled before-after clinical trial

Publisher

England: BioMed Central Ltd

Journal title

BMC infectious diseases, 2025-03, Vol.25 (1), p.441-13, Article 441

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Pneumonia Compound Formulation (PCF) is a traditional Chinese medicine (TCM) formula used for the clinical treatment of novel coronavirus pneumonia. However, its efficacy and mechanism of action for community-acquired pneumonia (CAP) are unknown. Therefore, the aim of this study was to evaluate the efficacy of PCF combined with antibiotics in the t...

Alternative Titles

Full title

Efficacy and metabolomic analysis of the pneumonia compound formulation against community-acquired pneumonia: an observational controlled before-after clinical trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_8f58dd06bb8c4508a8d6feb357df91a1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8f58dd06bb8c4508a8d6feb357df91a1

Other Identifiers

ISSN

1471-2334

E-ISSN

1471-2334

DOI

10.1186/s12879-025-10823-8

How to access this item